Inovio Pharmaceuticals Launch: A Proven Step Forward

Inovio Pharmaceuticals launch marks a significant milestone after FDA approval, paving the way for innovative treatments.

Lung cancer drug approval: Is it the best option for patients?

Lung cancer drug approval is a significant milestone for Alembic Pharma, enhancing treatment options.

Sushi-monjaro imports: Are They the Best Solution for Drug Prices?

Sushi-monjaro imports could impact obesity drug prices in Korea. Discover the implications today.

Cancer Drug Price Cuts: Smart Move to Save Rs 3,502 Crore

Cancer drug price cuts are set to save Rs 3,502 crore annually, benefiting patients and healthcare.

Amber Enterprises acquisition: Proven strategy for growth

Amber Enterprises acquisition is a significant move in the pharma sector, enhancing market presence and capabilities.

India Medicine Pricing: The Real Gaps Exposed by Drug Cuts

India medicine pricing reveals significant gaps in affordability and access.

Anti Cancer Drugs: The Real Impact of Price Cuts Revealed

Anti cancer drugs are under scrutiny as public health campaigners question the Centre’s recent price cuts.

Stroke-prevention drug: Safe New Class with Proven Benefits

Stroke-prevention drug approval in China marks a global first for Bayer, offering new hope in treatment.

Hepatitis B Approval: Proven Cure Strategy Gains Focus

Hepatitis B Approval highlights GSK’s innovative approach to treatment.

Anuh Pharma Tarapur Plant: Proven Boost for API Capacity

Anuh Pharma Tarapur Plant acquisition boosts API capacity significantly. Discover the details behind this strategic move.